Voxelotor 500 mg Oral Tablet
RxNorm 2265683
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2265683 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: voxelotor 500 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Voxelotor 500 mg Oral Tablet
(Atom ID: 12350834)
PSN
Prescribable Name (PSN):
Voxelotor 500 mg Oral Tablet
(Atom ID: 11808227)
Patient Education
Voxelotor
Voxelotor is used to treat sickle cell disease (an inherited blood disease) in adults and children 12 years of age and older. Voxelotor is in a class of medications called hemoglobin S (HbS) polymerization inhibitors. It works by helping hemoglobin (a protein in red blood cells) to hold onto more oxygen and to stop red blood cells from becoming misshapen.
[Learn More]
* Please review the disclaimer below.